Serum Institute Of India


'Serum Institute Of India' - 35 News Result(s)

  • India's Serum Institute, Partners Join Race To Develop COVID-19 Treatment

    India's Serum Institute, Partners Join Race To Develop COVID-19 Treatment

    The Serum Institute of India on Thursday said it has entered into an agreement with German pharmaceutical giant Merck and New York-based non-profit health research organisation IAVI to develop a treatment for people infected by the coronavirus.

  • Serum Institute, Bharat Biotech To Start Nasal Vaccine Trials: Centre

    Serum Institute, Bharat Biotech To Start Nasal Vaccine Trials: Centre

    Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health Minister Dr Harsh Vardhan said today.

  • "Don't Agree With Rs 80,000 Crore Figure For COVID Vaccine Distribution": Centre

    "Don't Agree With Rs 80,000 Crore Figure For COVID Vaccine Distribution": Centre

    The Union Health Ministry has said it does not agree with the Rs 80,000 crore figure cited by Adar Poonawalla, CEO of Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting trials of Covid vaccine candidates ahead of mass production - for buying and distributing the vaccine in the country. The Mini...

  • Serum Institute Says Will Make Additional 100 Million Covid Vaccine Doses

    Serum Institute Says Will Make Additional 100 Million Covid Vaccine Doses

    Serum Institute of India said on Tuesday it would get a further $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make an additional 100 million COVID-19 vaccine doses for India and other low- and middle-income countries next year.

  • Adar Poonawalla's Praise For PM On Providing Vaccine To Global Community

    Adar Poonawalla's Praise For PM On Providing Vaccine To Global Community

    Adar Poonawalla, the CEO of the Serum Institute of India, took to Twitter today to praise Prime Minister Narendra Modi's speech at the United Nations General Assembly on COVID-19 vaccines a day after he highlighted the challenges in vaccine production and distribution in the country.

  • "Will Centre Have 80,000 Crore For Covid Vaccines" Adar Poonawalla Asks

    "Will Centre Have 80,000 Crore For Covid Vaccines" Adar Poonawalla Asks

    Adar Poonawalla, the CEO of the Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting Covid vaccine trials ahead of mass production - took to Twitter to highlight potential challenges ahead of vaccine production and distribution

  • Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week

    Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week

    The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University, and being manufactured by the Serum Institute of India (SII), will begin at the Sassoon General Hospital in Pune next week.

  • Coronavirus India Live Updates: Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    Coronavirus India Live Updates: Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    India's COVID-19 case tally has crossed the 50-lakh mark with a spike of 90,123 new cases and 1,290 deaths - the highest the country has seen in 24 hours, the Union Health Ministry said. The total number of people who have died because of the disease now stands at 80,776.

  • Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.

  • US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal

    US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal

    US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.

  • Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume

    Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume

    The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening

  • Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment

    Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment

    New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.

  • Serum Institute Ordered To Suspend Recruitment For Covid Vaccine Trials

    Serum Institute Ordered To Suspend Recruitment For Covid Vaccine Trials

    Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries.

  • Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice

    Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice

    Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in...

  • Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial

    Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial

    The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DCGI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the...

'Serum Institute Of India' - 16 Video Result(s)

'Serum Institute Of India' - 35 News Result(s)

  • India's Serum Institute, Partners Join Race To Develop COVID-19 Treatment

    India's Serum Institute, Partners Join Race To Develop COVID-19 Treatment

    The Serum Institute of India on Thursday said it has entered into an agreement with German pharmaceutical giant Merck and New York-based non-profit health research organisation IAVI to develop a treatment for people infected by the coronavirus.

  • Serum Institute, Bharat Biotech To Start Nasal Vaccine Trials: Centre

    Serum Institute, Bharat Biotech To Start Nasal Vaccine Trials: Centre

    Serum Institute of India and Bharat Biotech are expected to pursue late stage clinical trials of intranasal COVID-19 vaccines in the coming months once they receive regulatory approval, Health Minister Dr Harsh Vardhan said today.

  • "Don't Agree With Rs 80,000 Crore Figure For COVID Vaccine Distribution": Centre

    "Don't Agree With Rs 80,000 Crore Figure For COVID Vaccine Distribution": Centre

    The Union Health Ministry has said it does not agree with the Rs 80,000 crore figure cited by Adar Poonawalla, CEO of Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting trials of Covid vaccine candidates ahead of mass production - for buying and distributing the vaccine in the country. The Mini...

  • Serum Institute Says Will Make Additional 100 Million Covid Vaccine Doses

    Serum Institute Says Will Make Additional 100 Million Covid Vaccine Doses

    Serum Institute of India said on Tuesday it would get a further $150 million in funding from the Bill & Melinda Gates Foundation and the GAVI vaccines alliance to make an additional 100 million COVID-19 vaccine doses for India and other low- and middle-income countries next year.

  • Adar Poonawalla's Praise For PM On Providing Vaccine To Global Community

    Adar Poonawalla's Praise For PM On Providing Vaccine To Global Community

    Adar Poonawalla, the CEO of the Serum Institute of India, took to Twitter today to praise Prime Minister Narendra Modi's speech at the United Nations General Assembly on COVID-19 vaccines a day after he highlighted the challenges in vaccine production and distribution in the country.

  • "Will Centre Have 80,000 Crore For Covid Vaccines" Adar Poonawalla Asks

    "Will Centre Have 80,000 Crore For Covid Vaccines" Adar Poonawalla Asks

    Adar Poonawalla, the CEO of the Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting Covid vaccine trials ahead of mass production - took to Twitter to highlight potential challenges ahead of vaccine production and distribution

  • Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week

    Phase 3 Trial Of Oxford Vaccine To Begin In Pune Next Week

    The phase-III human clinical trial of the COVID-19 vaccine developed by Oxford University, and being manufactured by the Serum Institute of India (SII), will begin at the Sassoon General Hospital in Pune next week.

  • Coronavirus India Live Updates: Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    Coronavirus India Live Updates: Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    India's COVID-19 case tally has crossed the 50-lakh mark with a spike of 90,123 new cases and 1,290 deaths - the highest the country has seen in 24 hours, the Union Health Ministry said. The total number of people who have died because of the disease now stands at 80,776.

  • Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India

    Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.

  • US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal

    US Firm Novavax Aims For 2 Billion COVID Vaccine Doses With Expanded India Deal

    US drug developer Novavax said on Tuesday it was doubling its potential COVID-19 vaccine manufacturing capacity to two billion doses annually under an agreement with Serum Institute of India, sending its shares up about 7%.

  • Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume

    Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume

    The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening

  • Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment

    Adar Poonawalla's Serum Institute Told To Pause Vaccine Trial Recruitment

    New recruitment for the Phase 2 and Phase 3 trials of the Oxford University's Covishield vaccine being manufactured in India by the Serum Institute of India, along with pharma major AstraZeneca, has to be suspended till further orders, country's drug controller DCGI has said.

  • Serum Institute Ordered To Suspend Recruitment For Covid Vaccine Trials

    Serum Institute Ordered To Suspend Recruitment For Covid Vaccine Trials

    Drugs Controller General of India (DCGI) has directed Serum Institute of India to suspend till further orders new recruitment in phase 2 and 3 clinical trials of the Oxford COVID-19 vaccine candidate in the backdrop of pharma giant AstraZeneca pausing the trials in other countries.

  • Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice

    Serum Institute To Pause Vaccine Trials In India After Drug Controller's Notice

    Serum Institute of India, which is manufacturing the coronavirus vaccine Covishield being developed by the Oxford University along with pharma major AstraZenca, today said it will stop the Phase 3 trials that were to begin in India next week. The vaccine trial was stopped across four nations as a precautionary measure after one of the recipients in...

  • Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial

    Adar Poonawalla's Serum Institute Gets Notice on Pausing Vaccine Trial

    The Serum Institute of India, which is manufacturing the Oxford University's Covishield vaccine and will hold the phase 3 clinical trials in India from next week, has been issued a showcause notice by the country's drug controller DCGI. Trials for the vaccine were stopped in four nations as a precautionary measure after one of the recipients in the...

'Serum Institute Of India' - 16 Video Result(s)

Your search did not match any documents
A few suggestions
  • Make sure all words are spelled correctly
  • Try different keywords
  • Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com

................................ Advertisement ................................

................................ Advertisement ................................

Listen to the latest songs, only on JioSaavn.com